scholarly journals The Use of the Apparent Diffusion Coefficient (ADC) for Characterization and Differentiation of Focal Hepatic Lesions in Noncirrhotic Patients.

Author(s):  
Jonatan William Rodrigues Justo ◽  
Guilherme Watte ◽  
Bruno Hochhegger

Abstract PURPOSE Diffusion-weighted imaging (DWI) is a MRI technique that, although relatively recent, has shown promise for the evaluation of focal hepatic lesions, providing information both on qualitative and quantitative parameters. The present study was designed to analyze the role of DWI, particularly the ADC (apparent diffusion coefficient), in differentiating benign solid liver lesions from malignant ones in a sample of noncirrhotic patients. METHODS We conducted a retrospective analysis of MRI scans performed at a tertiary hospital in Porto Alegre, Rio Grande do Sul, Brazil, from 2015 to 2018. The distribution of lesions into benign vs. malignant groups was determined by imaging criteria and/or histological analysis. ADC were obtained for each lesion.RESULTS Overall, 118 focal liver lesions were evaluated, with 78 benign and 40 malignant. The mean ADC value was 1.420×10−3 mm2/s for benign lesions versus 1.130×10−3 mm2/s for malignant lesions (p<0.001). ROC curve analysis showed an area under the curve of 0.79, optimal cutoff point of 1.19×10−3 mm2/s for discriminating between malignant and benign lesions, sensitivity and specificity of 75% and 73.1%.CONCLUSIONS We demonstrate the appropriateness of ADC for characterization of benign solid lesions of the liver and to distinguish these masses from malignant metastatic lesions.

2012 ◽  
Vol 22 (11) ◽  
pp. 2514-2524 ◽  
Author(s):  
Andrzej Cieszanowski ◽  
Agnieszka Anysz-Grodzicka ◽  
Wojciech Szeszkowski ◽  
Bartosz Kaczynski ◽  
Edyta Maj ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Sherif Abugamra ◽  
Aya Yassin ◽  
Asmaa Saber Mostafa Abdel-Rehim ◽  
Dina Sayed Sheha

Abstract Background The aim of this study was to prospectively evaluate the role of diffusion weight MRI (DWI) in the characterization of hepatic focal lesions by using apparent diffusion coefficient (ADC). Thirty patients (18 women, 12 men; mean age 48.5 years) with hepatic focal lesions were included in this study. Patients underwent DW MR imaging with the SPLICE sequence. ADC of each focal lesion carcinoma was calculated from DW MR Images obtained with low and high b values. ADCs were compared among pathological types of focal lesions. Results Among the 30 patients included in the study, 46 focal lesions were detected. Twenty-four lesions were metastatic lesions from primary cancer, 7 lesions were hepatocellular carcinoma (HCC), 9 lesions were hemangiomas, and 6 lesions were simple cysts. There was highly significant difference between the mean ADC of the malignant lesions (metastasis and HCC) and the mean ADC of benign lesions (hemangiomas and cysts). The ADC of malignant lesion was much less than that of benign lesion. The mean ADC of malignant lesions (n = 31) was 0.73 ± 0.19 × 10−3 mm2/s, and the mean ADC of benign lesions (n = 15) was 1.94 ± 0.68 × 10−3 mm2/s (p value < 0.001). There was no significant difference between the cysts and hemangiomas. There was no statistically significant difference between the metastases and hepatocellular carcinoma. Conclusion ADCs values were able to differentiate benign from malignant lesions. ADC should be considered in the work up of patients with hepatic focal lesions.


Author(s):  
Alexey Surov ◽  
Hans-Jonas Meyer ◽  
Maciej Pech ◽  
Maciej Powerski ◽  
Jasan Omari ◽  
...  

Abstract Background Our aim was to provide data regarding use of diffusion-weighted imaging (DWI) for distinguishing metastatic and non-metastatic lymph nodes (LN) in rectal cancer. Methods MEDLINE library, EMBASE, and SCOPUS database were screened for associations between DWI and metastatic and non-metastatic LN in rectal cancer up to February 2021. Overall, 9 studies were included into the analysis. Number, mean value, and standard deviation of DWI parameters including apparent diffusion coefficient (ADC) values of metastatic and non-metastatic LN were extracted from the literature. The methodological quality of the studies was investigated according to the QUADAS-2 assessment. The meta-analysis was undertaken by using RevMan 5.3 software. DerSimonian, and Laird random-effects models with inverse-variance weights were used to account the heterogeneity between the studies. Mean DWI values including 95% confidence intervals were calculated for metastatic and non-metastatic LN. Results ADC values were reported for 1376 LN, 623 (45.3%) metastatic LN, and 754 (54.7%) non-metastatic LN. The calculated mean ADC value (× 10−3 mm2/s) of metastatic LN was 1.05, 95%CI (0.94, 1.15). The calculated mean ADC value of the non-metastatic LN was 1.17, 95%CI (1.01, 1.33). The calculated sensitivity and specificity were 0.81, 95%CI (0.74, 0.89) and 0.67, 95%CI (0.54, 0.79). Conclusion No reliable ADC threshold can be recommended for distinguishing of metastatic and non-metastatic LN in rectal cancer.


Sign in / Sign up

Export Citation Format

Share Document